Article
[News treatments and survival in lung cancer].
La Revue du praticien - 1 Jan 2023
Lamkhioued Mehdi, Pierret Thomas
Abstract excerpt
NEW TREATMENTS AND SURVIVAL IN LUNG CANCER. Treatment paradigm for non-squamous cell lung cancer (NSCLC) has evolved dramatically in the early 2000s, mainly because of the identification of targetable oncogenes such as EGFR (epidermal growth factor receptor) and ALK (anaplasic lymphome kinase). Incidence and mortality have both declined thanks to the development of novel therapies. Since major diagnosis and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
